Suppr超能文献

血液透析人群中丙型肝炎病毒微观消除的更新路径

Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population.

作者信息

Rajasekaran Arun, Franco Ricardo A, Overton Edgar T, McGuire Brendan M, Towns Graham C, Locke Jayme E, Sawinski Deirdre L, Bell Emmy K

机构信息

Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.

出版信息

Kidney Int Rep. 2021 Apr 25;6(7):1788-1798. doi: 10.1016/j.ekir.2021.04.015. eCollection 2021 Jul.

Abstract

Chronic hepatitis C virus (HCV) infection continues to be transmitted to hemodialysis (HD) patients within HD facilities globally. The goal of the World Health Organization to micro-eliminate HCV infection from the HD population by the year 2030 is not on target to be achieved. Obstacles to eliminate HCV in HD settings remain daunting due to a complex system created by a confluence of guidelines, legislation, regulation, and economics. HCV prevalence remains high and seroconversion continues among the HD patient population globally as a result of the HD procedure. Preventive strategies that effectively prevent HCV transmission, treatment-as-prevention, and rapid referral to treatment balanced with kidney transplant candidacy should be added to the current universal precautions approach. A safer system must be designed before HCV transmission can be halted and eliminated from the HD population.

摘要

慢性丙型肝炎病毒(HCV)感染在全球范围内的血液透析(HD)设施中持续传播给HD患者。世界卫生组织到2030年在HD人群中实现丙型肝炎病毒感染微观消除的目标未能按计划实现。由于指南、立法、监管和经济因素交汇形成的复杂系统,在HD环境中消除HCV的障碍仍然艰巨。由于HD程序,全球HD患者群体中HCV流行率仍然很高且血清转换仍在继续。应在当前的通用预防措施方法中增加有效预防HCV传播、治疗即预防以及在肾移植候选资格之间实现快速转诊治疗的预防策略。必须设计一个更安全的系统,才能在HD人群中停止并消除HCV传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9a9/8258460/f775e4ea0b85/gr1.jpg

相似文献

1
Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population.
Kidney Int Rep. 2021 Apr 25;6(7):1788-1798. doi: 10.1016/j.ekir.2021.04.015. eCollection 2021 Jul.
3
Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis.
Nephron Clin Pract. 2006;104(1):c1-6. doi: 10.1159/000093252. Epub 2006 May 9.
5
Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus.
Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):302-6. doi: 10.1016/s1499-3872(12)60164-7.
6
Updated Evidence on the Epidemiology of Hepatitis C Virus in Hemodialysis.
Pathogens. 2021 Sep 7;10(9):1149. doi: 10.3390/pathogens10091149.
7
Hepatitis and HIV infection during haemodialysis.
J Indian Med Assoc. 2001 Apr;99(4):194-9, 203, 213.
9
Hepatitis C in hemodialysis: epidemiology and prevention of hepatitis C virus transmission.
Contrib Nephrol. 2012;176:35-41. doi: 10.1159/000333761. Epub 2012 Jan 30.

引用本文的文献

本文引用的文献

1
Technology integration in complex healthcare environments: A systematic literature review.
Appl Ergon. 2021 Apr;92:103351. doi: 10.1016/j.apergo.2020.103351. Epub 2021 Jan 4.
3
US Renal Data System 2019 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Am J Kidney Dis. 2020 Jan;75(1 Suppl 1):A6-A7. doi: 10.1053/j.ajkd.2019.09.003. Epub 2019 Nov 5.
4
Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C.
JAMA Netw Open. 2019 Jun 5;2(6):e194765. doi: 10.1001/jamanetworkopen.2019.4765.
5
Technology barriers and strategies in coordinating care for chronically ill patients.
Appl Ergon. 2019 Jul;78:240-247. doi: 10.1016/j.apergo.2019.03.009. Epub 2019 Apr 2.
6
Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):244-254. doi: 10.1016/j.clinre.2018.10.009. Epub 2019 Mar 23.
7
Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
Kidney Int. 2019 Apr;95(4):939-947. doi: 10.1016/j.kint.2018.11.038.
9
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
10
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验